ANNA MESSER: Open Payments
NPI 1730742354 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 8 payments from 6 companies in 2025. Trend: 2023 $604 · 2024 $436 · 2025 $688
Food & beverage: $505Education: $183
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $200 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Amgen Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $94 |
| Melinta Therapeutics, LLC | 1 | $26 |
Products named: PREVYMIS, REXULTI, BLINCYTO, Rezzayo, Cresemba.
Industry payments across AL — which companies pay providers there.
